149 articles related to "India"
Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug
Further compulsory licences on high-price patented medicines expected 18 January 2013 - This week, final hearings began in Chennai, India, in the appeal that German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 18 January 2013
HIV+ People and MSF Protest Outside Novartis Headquarters In Mumbai Ahead of Verdict in Novartis Vs. India Supreme Court Case
MUMBAI, 21 December 2012 -- As the Supreme Court considers its verdict in the case of Swiss pharmaceutical company Novartis vs. the Indian government, people living with HIV, Sankalp Rehabilitation...
Press Release – Last updated 26 December 2012
After 12 weeks of hearings in India's Supreme Court, Médecins Sans Frontières (MSF) has learnt that final arguments into the Novartis vs. Union of India case challenging the interpretation...
Web article – Last updated 04 December 2012
UPDATE ON THE CASE Hearings into the case commenced on 11 September 2012, with representatives for Novartis being the first to present their arguments. The court has also heard arguments from generic...
Web article – Last updated 16 November 2012
Multimedia – Last updated 25 September 2012
17 September 2012 - India's Intellectual Property Appellate Board (IPAB) has dismissed Bayer’s request for a stay order against the compulsory licence granted by the Patent Controller...
Statements, Speeches, Letters – Last updated 17 September 2012
German company appeals against life-saving compulsory licence decision in India Geneva/New Delhi, 3 September, 2012 – German pharmaceutical company Bayer today heads to India’s Intellectual...
Press Release – Last updated 26 September 2012
Novartis and Bayer are both charging exhorbitant prices for medicines in India as they continue their fight against the country's patent law that puts people over profits in the name of access to...
Web article – Last updated 11 September 2012
Case could negatively impact India’s role as ‘pharmacy of the developing world’ New Delhi/Geneva 11 September 2012 – Swiss pharmaceutical company Novartis heads to the Indian...
Press Release – Last updated 11 September 2012
Médecins Sans Frontières (MSF) has learnt that India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 21 August 2012